1. Home
  2. AIXI vs CNSP Comparison

AIXI vs CNSP Comparison

Compare AIXI & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIXI

XIAO-I Corporation

HOLD

Current Price

$0.23

Market Cap

3.7M

Sector

Technology

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$3.63

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIXI
CNSP
Founded
2001
2017
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.8M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
AIXI
CNSP
Price
$0.23
$3.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
637.5K
78.9K
Earning Date
04-24-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,877,458.00
N/A
Revenue This Year
$26.84
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$3.63
52 Week High
$5.49
$114.00

Technical Indicators

Market Signals
Indicator
AIXI
CNSP
Relative Strength Index (RSI) 41.72 21.98
Support Level $0.20 $3.63
Resistance Level $0.28 $4.62
Average True Range (ATR) 0.03 0.39
MACD 0.01 -0.21
Stochastic Oscillator 70.45 0.00

Price Performance

Historical Comparison
AIXI
CNSP

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: